Isovue-M-300 Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Isovue-M-300
L
- L-Caine (lidocaine)
- labetalol
- lamivudine / tenofovir
- lansoprazole / naproxen
- Lantex-LA (guaifenesin / phenylpropanolamine)
- Larapam SR (tramadol)
- Largon (propiomazine)
- Lariam (mefloquine)
- Lasix (furosemide)
- latanoprost / timolol ophthalmic
- Latuda (lurasidone)
- Lazanda (fentanyl)
- Leader Naproxen Sodium (naproxen)
- Levall 5.0 (guaifenesin / hydrocodone / phenylephrine)
- Levaquin (levofloxacin)
- Levaquin Leva-Pak (levofloxacin)
- Levatol (penbutolol)
- Levo-Dromoran (levorphanol)
- levobetaxolol ophthalmic
- levobunolol ophthalmic
- levofloxacin
- levomethadyl acetate
- levomilnacipran
- Levoprome (methotrimeprazine)
- levorphanol
- Lexapro (escitalopram)
- Lexuss 210 (chlorpheniramine / codeine)
- Lialda (mesalamine)
- lidocaine
- lidocaine / oxytetracycline
- lidocaine / potassium chloride
- lidocaine / sodium bicarbonate
- lidocaine / tetracaine
- Lidoject 1 (lidocaine)
- Lidoject 2 (lidocaine)
- LidoSite (epinephrine / lidocaine)
- lifileucel
- Lignospan (epinephrine / lidocaine)
- Lignospan Forte (epinephrine / lidocaine)
- Limbitrol (amitriptyline / chlordiazepoxide)
- Limbitrol DS (amitriptyline / chlordiazepoxide)
- linagliptin / metformin
- lindane topical
- Liquadd (dextroamphetamine)
- Liqui-Histine-D (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine)
- Liqui-Minic Infant (pheniramine / phenylpropanolamine / pyrilamine)
- Liquicet (acetaminophen / hydrocodone)
- Liquicough HC (chlorpheniramine / hydrocodone / phenylephrine)
- Liquihistine CS (brompheniramine / codeine / phenylpropanolamine)
- Liquihistine DM (brompheniramine / dextromethorphan / phenylpropanolamine)
- Liquituss HD (hydrocodone / pseudoephedrine)
- Liquitussin HC Syrup (chlorpheniramine / hydrocodone / phenylephrine)
- lisdexamfetamine
- lithium
- Lithium Carbonate ER (lithium)
- Lithobid (lithium)
- Lithonate (lithium)
- Lithotabs (lithium)
- Lo-Aqua (furosemide)
- LoCort (dexamethasone)
- Lodine (etodolac)
- Lodine XL (etodolac)
- Lofena (diclofenac)
- Lomaira (phentermine)
- lomefloxacin
- Lopressor (metoprolol)
- Lopressor HCT (hydrochlorothiazide / metoprolol)
- Loqua (hydrochlorothiazide)
- Lorcet (acetaminophen / hydrocodone)
- Lorcet 10 / 650 (acetaminophen / hydrocodone)
- Lorcet HD (acetaminophen / hydrocodone)
- Lorcet Plus (acetaminophen / hydrocodone)
- Lortab (acetaminophen / hydrocodone)
- Lortab ASA (aspirin / hydrocodone)
- Lortuss EX (codeine / guaifenesin / pseudoephedrine)
- Lortuss HC (hydrocodone / phenylephrine)
- Lotensin HCT (benazepril / hydrochlorothiazide)
- loxapine
- Loxitane (loxapine)
- Loxitane C (loxapine)
- Loxitane IM (loxapine)
- Lozol (indapamide)
- Ludiomil (maprotiline)
- Lufyllin-EPG (dyphylline / ephedrine / guaifenesin / phenobarbital)
- lumateperone
- Lumoxiti (moxetumomab pasudotox)
- Lupkynis (voclosporin)
- lurasidone
- Lutathera (lutetium lu 177 dotatate)
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- Luvox (fluvoxamine)
- Luvox CR (fluvoxamine)
- Lybalvi (olanzapine / samidorphan)
- Lyphocin (vancomycin)
More about Isovue-M-300 (iopamidol)
- Isovue-M-300 consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.